Equity
€20,727 from €109,208 in 2022
Equity fell by 81% in 3 years.
MEDRG
Lifetime
8 annual accounts with figures on one time axispeak €140,157 (2025)
€140,157▲ 23.4%
lowest -€34,287 (2020)
€77,451▲ 5.8%
peak €109,208 (2022)
€20,727▼ 2.6%
€224,420▲ 9.3%
peak 0.1 FTE (2025)
0.1 FTE
Board3 names since 2017
3 directors and 2 others
Owners2 names in the annual accounts
Documentsfilings and deeds
05-06-202656 days before the deadline
2025financial year
Gross margin from €113,537 to €140,157Dividend €78,000Cash from €43,660 to €6,639
Key points
from the 2025 annual accountsTurnover
≈ €260,000 estimated
The accounts state no turnover.
Debts
€224,420 92% of the balance sheet
Financial debts 48%Suppliers 0%Taxes and wages 9%Other 42%
Of this, €116,340 falls due within a year.
Filings
8 annual accounts 1 late
The 2021 accounts came 18 days late. The other seven were filed on time.
Starting capital
€18,600 100 shares
Position in the sector
€20,727
Less equity than 86% of companies in human health. Sector median €454,183 · 505 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 2,154 companies had the same profile as MEDRG has now. Each dot stands for 6 companies, two years later.
96.0%
were still trading
2.3%
stopped another way
1.7%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 2,154 companies, not a prediction for MEDRG. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Manager
Director
Director
- 50%annual accounts 2021
- 50%annual accounts 2021
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0684690336
Appointment: (director)
General meeting of 17-06-2024 · Gazette deed
Amendment of the articles · Legal-form change · Resignations & appointments
Gazette deed
Registered office moved from Esneux to Tilff
New registered office: Avenue des Ardennes 174 4130 Tilff · Previous registered office: Avenue de la Grotte 55 à 4130 Esneux · Board meeting of 31-08-2022 · Gazette deed
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| MEDRG Esneux | €245,147 | €140,157 | 8.5% | 0.1 |
| AmbEryn Bertem | €266,500 | €122,554 | 84.1% | 0 |
| DR. MKM BERGOETS Schilde | €382,465 | €116,692 | 64.0% | 0 |
| DOKTER TINE CORNELIS Oud-Heverlee | €150,897 | €169,502 | 97.1% | 0 |
| LEJON-URG Diepenbeek | €181,524 | €203,004 | 85.3% | 0 |
| Labo Kris Mervillie Nazareth-De Pinte | €351,067 | €140,843 | 67.2% | 0.5 |
| Dokter Liesbet De Wachter Leuven | €296,602 | €106,245 | 22.0% | 0 |
These companies have the same main activity as MEDRG: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €151,000 and €382,000, founded between 2014 and 2021.
Official details
Source: KBO- Status
- Active since 14-11-2017Normal situation
- Activity
- Specialist medical practiceNACE 86220
- Establishment unit
- 2.335.494.2394130 Esneux, since 14-11-2017
- Financial year end
- 31 December
- Peppol
- Reachable since 25-09-2025
Annual accounts 2025
- €245,147▲ 8.2%
- Filing
- Filed on 05-06-2026, 56 days before the end of the filing period
Insights on MEDRG
MEDRG has existed since 2017. The gross margin grew from €67,357 in 2018 to €140,157 in 2025.
The gross margin has grown every year since 2022.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about MEDRG
- What is the company number of MEDRG?
- The company number of MEDRG is 0684.690.336. The VAT number is the same number with BE in front: BE 0684.690.336.
- Where is MEDRG based?
- The registered office is at Avenue des Ardennes 174, 4130 Esneux.Company details
- What does MEDRG do?
- According to the KBO register, the main activity is specialist medical practice (NACE 86220).
- What is the legal form of MEDRG?
- MEDRG is a private limited company (BV).
- When was MEDRG founded?
- MEDRG was founded on 14-11-2017.
- Is MEDRG still active?
- Yes, MEDRG is an active enterprise in the KBO register.
- How many employees does MEDRG have?
- MEDRG had an average of 0.1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of MEDRG?
- The turnover in financial year 2025 is ≈ €260,000. This figure is estimated from the gross margin of €140,157 and 40 comparable companies (NACE 86220). It probably lies between €220,000 and €350,000.
- Is MEDRG profitable?
- In financial year 2025, MEDRG made a profit of €77,451.
- Where can I find the annual accounts of MEDRG?
- MEDRG filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of MEDRG due?
- MEDRG must file the annual accounts for financial year 2026 by 31-07-2027.Timeline
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.